Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PRGO - Perrigo Company plc
Market Cap 4.91B P/E - EPS this Y -8.90% Ern Qtrly Grth -
Income -4.4M Forward P/E 11.52 EPS next Y 25.10% 50D Avg Chg 7.00%
Sales 4.66B PEG 1.33 EPS past 5Y -13.46% 200D Avg Chg 3.00%
Dividend 3.00% Price/Book 1.02 EPS next 5Y 10.00% 52W High Chg -17.00%
Recommedations 1.70 Quick Ratio 0.95 Shares Outstanding 135.52M 52W Low Chg 18.00%
Insider Own 0.31% ROA 1.64% Shares Float 134.68M Beta 0.65
Inst Own 99.44% ROE -0.09% Shares Shorted/Prior 3.90M/3.74M Price 36.30
Gross Margin 36.09% Profit Margin -0.27% Avg. Volume 1,186,327 Target Price 40.50
Oper. Margin 7.94% Earnings Date May 7 Volume 868,674 Change -0.14%
Healthcare | Drug Manufacturers - Specialty & Generic | Ireland
About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Company plc News
04/25/24 Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
04/23/24 Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
04/15/24 Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
04/11/24 The WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control
04/09/24 Opill and WNBA Team Up for Groundbreaking Partnership
04/04/24 CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors
03/28/24 Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
03/18/24 Prepare for Takeoff With Perrigo
03/05/24 Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript
03/04/24 First over-the-counter birth control pill in US begins shipping to stores
03/04/24 Over-the-Counter Birth Control Pill to Be Available Within Weeks on Retail Shelves
03/04/24 Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States
03/03/24 Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
03/02/24 Here's Why We're Wary Of Buying Perrigo's (NYSE:PRGO) For Its Upcoming Dividend
03/01/24 Perrigo (NYSE:PRGO) Is Paying Out A Larger Dividend Than Last Year
02/29/24 Perrigo to Attend UBS Global Consumer and Retail Conference
02/27/24 Perrigo (PRGO) Q4 Earnings Top, Sales Lag Estimates, Misses View
02/27/24 Compared to Estimates, Perrigo (PRGO) Q4 Earnings: A Look at Key Metrics
02/27/24 Perrigo Co PLC (PRGO) Posts Record Net Sales in Q4 and FY 2023, Launches Efficiency Program
02/27/24 Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program
PRGO Chatroom

User Image 11thestate Posted - 1 day ago

$PRGO

User Image Faddafin Posted - 1 day ago

$PRGO

User Image Stock_Titan Posted - 1 day ago

$PRGO Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million https://www.stocktitan.net/news/PRGO/perrigo-receives-binding-offer-to-divest-its-hra-pharma-rare-w8ndgv9hqvu8.html

User Image Stock_Titan Posted - 3 days ago

$PRGO Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 https://www.stocktitan.net/news/PRGO/perrigo-to-release-first-quarter-2024-financial-results-on-may-7-ke4bw4yf2gp7.html

User Image Stan_Vick Posted - 5 days ago

🎉 Perrigo agreed to settle $97M with investors to end claims over $PRGO misguiding on its growth prospects. ✔️ Investors who purchased $PRGO on the TASE are also eligible! ✌🏾 You can check if you are eligible and submit for a payout here => https://11thestate.com/cases/perrigo-investor-settlement

User Image larryb500 Posted - 2 weeks ago

$PRGO any news on Opill running ahead of expectations or projections.

User Image 11thestate Posted - 2 weeks ago

$PRGO agreed to settle $97M with investors to end claims over the Mylan's purchase offer and to the financial issues. Claim submission info and details:https://11thestate.com/cases/perrigo-investor-settlement

User Image Stock_Titan Posted - 2 weeks ago

$PRGO Opill and WNBA Team Up for Groundbreaking Partnership https://www.stocktitan.net/news/PRGO/opill-and-wnba-team-up-for-groundbreaking-opc6oljpjo3h.html

User Image itsallaboutheoptions Posted - 2 weeks ago

💬 $FEMY $PRGO President Biden responds to former President Trump, stating, "I have news for Donald: voters will punish him in 2024 for overturning Roe v. Wade." Biden's remarks underscore the intense political debate surrounding reproductive rights and its potential impact on future elections. 🗳️🇺🇸 #FEMY #PRGO #Biden #Trump #RoevWade

User Image BelieveableTruthsVideos Posted - 2 weeks ago

$PRGO https://x.com/akbrews/status/1777037373320384515?s=46&t=7c63GZXOcuslD6h_KPJZ8g

User Image larryb500 Posted - 2 weeks ago

$PRGO any reads on sales of Opill ? Anybody know the projections in dollars of Opill,..

User Image Cutlass Posted - 3 weeks ago

$PRGO Perky 👀

User Image DonCorleone77 Posted - 3 weeks ago

$PRGO CVS to cover Perrigo birth control drug at no cost, Bloomberg reports CVS Health (CVS) drug plans will cover Perrigo's (PRGO) nonprescription oral birth control drug Opill at no cost for many plan sponsors, Fiona Rutherford and John Tozzi of Bloomberg report, citing a CVS pharmacy update dated March 28 that was seen by Bloomberg News.

User Image Faddafin Posted - 3 weeks ago

$PRGO back to the 20's

User Image Faddafin Posted - 3 weeks ago

$PRGO

User Image SiSuZone Posted - 03/29/24

$PRGO so what the rule from Supreme Court I need this to touch $40 like yesterday

User Image TheTradeHunter Posted - 1 month ago

$PFE 'Supreme Court Unlikely To Limit Access To Abortion Pill' - Washington Post $DARE $PFE $PRGO https://www.benzinga.com/general/biotech/24/03/37939876/supreme-court-unlikely-to-limit-access-to-abortion-pill-washington-post via @Benzinga

User Image anonapplicable Posted - 1 month ago

$PRGO still here avg 26.18😎

User Image MuchStonk Posted - 1 month ago

$PRGO Really liking how this has been setting up lately. looking to push to $32.17 and then $33.20 as next resistance

User Image Kher33 Posted - 1 month ago

$PRGO in just 2 days over 1K purchased - just on Amazon and this is just the 1 month pack. Hoping for huge success here.

User Image Kher33 Posted - 1 month ago

$PRGO https://people.com/opill-first-over-the-counter-birth-control-pill-now-available-where-to-buy-8610453

User Image MuchStonk Posted - 1 month ago

$PRGO

User Image BelieveableTruthsVideos Posted - 1 month ago

$PRGO $AMZN First ever to be sold OTC in US. Already on Amazon. https://www.amazon.com/Opill-Contraceptive-Control-Prescription-Strength/dp/B0CJYHQ3CB

User Image OoeyGooey Posted - 1 month ago

$PRGO Out +5.4%, still interested in Opill and what it means for women in the US so will consider buying in again on dips.

User Image alanschulik Posted - 1 month ago

$PRGO I just saw a big coming soon sign for Opill in Walgreens

User Image Broview Posted - 1 month ago

$PRGO solid earnings?

User Image BelieveableTruthsVideos Posted - 1 month ago

$PRGO $ABT https://x.com/marketcurrents/status/1768759297998205341?s=46&t=7c63GZXOcuslD6h_KPJZ8g

User Image hundhaus3 Posted - 1 month ago

$PRGO Love it. Hit it's head right on the $31 resistance. Now on Monday when everyone reloads options you have no idea where it's going as it's stuck between $27-$31. I think depending on news insiders get determines the next direction closer to ER. If they are executing I expect $31 will get taken out beforehand. Long-term target is still $45 here.

User Image BelieveableTruthsVideos Posted - 1 month ago

$PRGO support is around this area. If it climbs back past $30 it could be a green turnaround day for a Friday that would be shocking

User Image BelieveableTruthsVideos Posted - 1 month ago

$PRGO https://www.tipranks.com/news/blurbs/perrigos-strategic-shift-to-self-care-and-infant-formula-sector-poised-for-growth-beyond-2024

Analyst Ratings
Canaccord Genuity Buy Apr 12, 24
Piper Sandler Overweight Apr 8, 24
JP Morgan Overweight Feb 28, 24
Piper Sandler Overweight Nov 17, 23
JP Morgan Overweight Aug 9, 23
Canaccord Genuity Buy Mar 7, 23
Raymond James Outperform Mar 6, 23
Raymond James Outperform Nov 9, 22
Argus Research Buy Sep 14, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Willis Robert EVP & CHRO EVP & CHRO Nov 24 Buy 31.01 5,550 172,106 19,105 11/27/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Nov 16 Buy 29.34 2,040 59,854 10,380 11/17/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Oct 06 Option 30.46 738 22,479 9,078 10/10/23
Manzone Albert Director Director Aug 15 Option 38.88 5,478 212,985 5,478 08/17/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Jul 07 Option 32.63 920 30,020 8,611 07/10/23
HANSON KYLE EVP & General Counse.. EVP & General Counsel Jul 07 Option 32.63 12,409 404,906 9,552 07/10/23
Parker Geoffrey M. Director Director Jun 13 Buy 33.0637 10,000 330,637 25,879 06/14/23
Andersen Svend EVP & President CHCI EVP & President CHCI May 23 Buy 33.4146 2,900 96,902 68,741 05/25/23
KESSLER MURRAY S CEO CEO May 11 Sell 35.7526 197,646 7,066,358 2,668 05/15/23
Dillard James E III EVP & President CSCA EVP & President CSCA Mar 10 Sell 35.701 9,000 321,309 25,130 03/14/23
Farrington Thomas EVP and CIO EVP and CIO Mar 13 Sell 35.58 3,723 132,464 2,823 03/14/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Mar 07 Option 37.71 1,746 65,842 8,201 03/09/23
Farrington Thomas EVP and CIO EVP and CIO Mar 06 Option 37.71 2,406 90,730 7,705 03/08/23
Parker Geoffrey M. Director Director Mar 06 Buy 38.054 5,000 190,270 15,879 03/07/23
Quinn Grainne EVP, Chief Medical O.. EVP, Chief Medical Officer Dec 16 Sell 31.65 2,368 74,947 9,118 12/20/22
Karaboutis Adriana Director Director May 17 Option 38.57 6,599 254,523 17,046 05/19/22
Doyle Katherine C. Director Director May 17 Option 38.57 6,599 254,523 9,530 05/19/22
O'Connor Donal Director Director May 17 Option 38.57 6,599 254,523 20,054 05/19/22
Mann Erica L Director Director May 17 Option 38.57 6,599 254,523 12,289 05/19/22
ASHFORD ORLANDO D Director Director May 17 Option 38.57 6,599 254,523 8,150 05/19/22
Samuels Theodore R. II Director Director May 17 Option 38.57 6,599 254,523 26,693 05/19/22
Alford Bradley A Director Director May 17 Option 38.57 6,599 254,523 30,577 05/19/22
Parker Geoffrey M. Director Director May 17 Option 38.57 6,599 254,523 14,829 05/19/22
KINDLER JEFFREY B Director Director May 17 Option 38.57 6,599 254,523 17,574 05/19/22
SILCOCK RAYMOND EVP, Chief Financial.. EVP, Chief Financial Officer Apr 05 Option 36.27 3,963 143,738 60,955 04/07/22
Farrington Thomas EVP and CIO EVP and CIO Mar 14 Sell 37.18 26,744 994,342 03/16/22
Willis Robert EVP & CHRO EVP & CHRO Mar 04 Option 37.23 5,012 186,597 9,760 03/08/22
Janish Ronald Craig EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO Mar 04 Option 37.23 5,410 201,414 20,559 03/08/22
Janish Ronald Craig EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO Mar 04 Sell 36.73 3,954 145,230 15,686 03/08/22
Farrington Thomas EVP and CIO EVP and CIO Mar 04 Option 37.23 4,424 164,706 25,185 03/08/22
ASHFORD ORLANDO D Director Director Mar 04 Option 37.23 2,984 111,094 2,984 03/08/22
KINGMA TODD W Executive VP, Genera.. Executive VP, General Counsel Mar 04 Option 37.23 8,911 331,757 46,677 03/08/22
Dillard James E III EVP & President CSCA EVP & President CSCA Mar 04 Option 37.23 7,002 260,684 24,148 03/08/22
Quinn Grainne EVP, Chief Medical O.. EVP, Chief Medical Officer Mar 04 Option 37.23 3,862 143,782 12,310 03/08/22
KESSLER MURRAY S CEO CEO Mar 04 Option 37.23 49,328 1,836,481 127,489 03/08/22
SILCOCK RAYMOND EVP, Chief Financial.. EVP, Chief Financial Officer Mar 04 Option 37.23 8,502 316,529 58,796 03/08/22
Andersen Svend EVP & President CHCI EVP & President CHCI Mar 04 Option 37.23 8,911 331,757 41,372 03/08/22
Dillard James E III EVP & President CSCA EVP & President CSCA Feb 07 Option 36.95 4,297 158,774 14,900 02/09/22
KESSLER MURRAY S CEO CEO Mar 09 Option 41.04 30,446 1,249,504 49,164 03/09/21
Kochan Sharon EVP & President Rx EVP & President Rx Mar 09 Option 41.04 4,057 166,499 38,748 03/09/21
Sorota Richard S EVP & President CSCA EVP & President CSCA Mar 09 Option 41.04 2,540 104,242 10,053 03/09/21
Farrington Thomas EVP and CIO EVP and CIO Mar 09 Option 41.04 2,730 112,039 18,468 03/09/21
Dillard James E III EVP, Chief Scientifi.. EVP, Chief Scientific Officer Mar 09 Option 41.04 4,322 177,375 11,173 03/09/21
Willis Robert EVP & CHRO EVP & CHRO Mar 09 Option 41.24 2,780 114,647 4,788 03/09/21
Quinn Grainne EVP, Chief Medical O.. EVP, Chief Medical Officer Mar 09 Option 41.04 2,279 93,530 7,299 03/09/21
Janish Ronald Craig EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO Mar 09 Option 41.04 3,339 137,033 14,835 03/09/21